Skip navigation

no spam, unsubscribe anytime.
Skip navigation
Goal: 30,000 Progress: 4,535
Sponsored by: The Autism Site

In 2015, America was outraged as the cost of a little-known drug called Daraprim skyrocketed overnight from $13.50 to $750 a pill. In 2016, the ubiquitous allergy medicine Epi-Pen rose from $100 to $600 in an instant.

Why? Profit.

These scandals are just two examples of a pervasive problem with American healthcare, which allows pharmaceutical companies to set prices as they see fit with a patchwork system of insurance providers. There are no restrictions of profit margins. There is little transparency in the pricing process. The result? Americans pay more for prescription drugs than any other nation in the world.

In most European countries, single-payer health systems use their size to negotiate big discounts, but the United States does not have a similar program and Obamacare did nothing to rein in the costs of prescription drugs when it was passed.

Clearly, something needs to change. When the price of lifesaving drugs suddenly goes from affordable to exorbitant, people deserve to understand why. When the VA is allowed to negotiate directly with drug companies, but Medicare is not, Medicare ends up with a deal that's better for the pharmaceutical companies than the people Medicare serves.

Two changes to current American policy would go a long way to ensuring pharmaceutical companies don't exploit the sick:

  1. Require drug-makers to justify the costs of their treatments and disclose major price hikes.
  2. Repeal the noninterference clause of the Medicare Modernization Act of 2003 which prevents Medicare, the single largest payer for health care in the U.S., from negotiating directly with drug companies.

Tell the Department of Health and Human Services enact the above legislation which would be a good start to controlling out-of-control drug prices in the United States. The American public shouldn't be expected to pad the pocketbooks of wealthy pharmaceutical executives! Lives are on the line.

Sign Here






To the Secretary of Health and Human Services,

I am writing to you to express my concern for the growing cost of prescription drugs in the United States. Pharmaceutical companies are taking advantage of ordinary, sick Americans, and it's up to you to do something about it.

Over the past few years, from Daraprim to EpiPen, we have seen a series of scandals emerge as pharmaceutical companies increase the prices of old drugs in an attempt to increase profits year after year. Since the United States has no single-payer healthcare system, this means the American public is being asked to shoulder the burden of these companies limitless greed at the cost of their health and financial stability.

Clearly, something needs to change. When the price of lifesaving drugs suddenly goes from affordable to exorbitant, people deserve to understand why. When the VA is allowed to negotiate directly with drug companies, but Medicare is not, Medicare ends up with a deal that's better for the pharmaceutical companies than the people Medicare serves.

Two changes to current American policy would go a long way to ensuring pharmaceutical companies don't exploit the sick:

  1. Require drug-makers to justify the costs of their treatments and disclose major price hikes.
  2. Repeal the noninterference clause of the Medicare Modernization Act of 2003 which prevents Medicare, the single largest payer for health care in the U.S., from negotiating directly with drug companies.

Please, enact the above policies which would be a good start to controlling out-of-control drug prices in the United States. The American public shouldn't be expected to pad the pocketbooks of wealthy pharmaceutical executives.

Petition Signatures


May 27, 2017 Elaine Greene
May 26, 2017 Linda Tabb
May 24, 2017 Suzanne Danielson
May 24, 2017 Diane Gravette
May 17, 2017 jane cook
May 14, 2017 Stephanie Linam
May 7, 2017 P D
Apr 25, 2017 Lindsey Holmes Peoples' health is more important than profit.
Apr 25, 2017 Deborah Bratcher
Apr 17, 2017 Sabrina Degasperi
Apr 16, 2017 Micah McVicker
Apr 13, 2017 Gilbert Christman
Apr 9, 2017 Lauri Moon
Apr 6, 2017 Deborah McDonald Protect people not pharmaceutical companies
Mar 27, 2017 skye rogerson
Mar 21, 2017 (Name not displayed)
Mar 14, 2017 Mick McMahon
Mar 13, 2017 Veronica Amador
Mar 13, 2017 Toni Robb
Mar 12, 2017 Kathleen Serrano
Mar 11, 2017 JACKIE MORRIS
Mar 11, 2017 Debbie Luchka
Mar 10, 2017 Amber Godown
Mar 9, 2017 Susan Lasky Jesella
Mar 9, 2017 (Name not displayed)
Mar 7, 2017 sara jagodič
Mar 7, 2017 julie wiebe
Mar 7, 2017 bill wiebe
Mar 6, 2017 Susan Bruce
Mar 6, 2017 Gertrud Bessai
Mar 6, 2017 karen patterson
Mar 6, 2017 Loda Maynor
Mar 5, 2017 (Name not displayed)
Mar 4, 2017 Muriel Heanue
Mar 4, 2017 (Name not displayed)
Mar 4, 2017 (Name not displayed) Soc. Security does not keep up with cost of living let alone the overnight spike in drug prices.
Mar 4, 2017 sandra corrigan
Mar 4, 2017 Suzanne Anderson
Mar 4, 2017 Barbara James
Mar 4, 2017 Gloria Darby
Mar 4, 2017 Karin Cohen
Mar 3, 2017 Jamie Smith
Mar 3, 2017 Darcie Wentworth
Mar 3, 2017 Alan Green
Mar 3, 2017 (Name not displayed)
Mar 3, 2017 Richard Bosboom
Mar 3, 2017 Emmanuel Xerias
Mar 2, 2017 Johanna Schroth
Mar 2, 2017 Ashleigh Heath
Mar 2, 2017 Dana Barry

back to top

Glass Bird Bath Collection
Floral Vines Sleeveless Tunic
Share this page and help fund therapy: